03024oam 2200841zu 450 991101931460332120251116150444.01-280-55869-597866105586983-527-60174-0(CKB)1000000000019230(SSID)ssj0000299344(PQKBManifestationID)11248039(PQKBTitleCode)TC0000299344(PQKBWorkID)10240813(PQKB)10379356(MiAaPQ)EBC5247763(Au-PeEL)EBL5247763(CaONFJC)MIL55869(OCoLC)806204146(EXLCZ)99100000000001923020160829d1999 uy engurcnu||||||||txtccrIminosugars as glycosidase inhibitors : Nojirimycin and beyond[Place of publication not identified]Wiley VCH19991 online resource (411 pages)Bibliographic Level Mode of Issuance: Monograph3-527-29544-5 Substances that inhibit sugar degradation in the body, so-called "glycosidase inhibitors" are used in the therapy of diabetes mellitus. They are important aids to explain the construction and degradation, particularly of complex carbohydrate side chains such as those found in glycoproteins and glycolipids. This book gives a representative cross-section of the field. A table of more than 400 glycosidase inhibitors completes the book.GlycosidasesInhibitorsImino compoundsPhysiological effectEnzyme InhibitorsGlycoside HydrolasesAmino SugarsCarbohydratesMolecular Mechanisms of Pharmacological ActionHydrolasesPharmacologic ActionsChemicals and DrugsEnzymesChemical Actions and UsesEnzymes and CoenzymesAnimal BiochemistryHILCCHuman Anatomy & PhysiologyHILCCHealth & Biological SciencesHILCCGlycosidasesInhibitors.Imino compoundsPhysiological effect.Enzyme Inhibitors.Glycoside Hydrolases.Amino Sugars.Carbohydrates.Molecular Mechanisms of Pharmacological Action.Hydrolases.Pharmacologic Actions.Chemicals and DrugsEnzymes.Chemical Actions and Uses.Enzymes and Coenzymes.Animal BiochemistryHuman Anatomy & PhysiologyHealth & Biological Sciences572/.793Stèutz Arnold EStütz Arnold E.PQKBBOOK9911019314603321Iminosugars as glycosidase inhibitors : Nojirimycin and beyond4416627UNINA